Analysed Bioxytran Inc (BIXT:OTCMKTS) News Sources
Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
USA TODAY
BIOXYTRAN, INC.: Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
FinanzNachrichten.de
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
Markets Insider
Red Lobster® Appoints Brad Hill as CFO and EVP, Transformation and Kristen Briede as Chief Global Development Officer
Le Lézard
PureLee Redefined Introduces Exomind, a Non-Pharmaceutical Treatment for Emotional and Mental Wellness
The Indianapolis Star
EmptyLegFinder.aero Processes Over 6,500 Private Flights in First Two Weeks Empty Leg Marketplace Gains Rapid Traction
azcentral.com
What is the current price of Bioxytran Inc (BIXT:OTCMKTS)?
The current price of Bioxytran Inc (BIXT:OTCMKTS) is $0.044.
Bioxytran Inc (BIXT:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Bioxytran Inc (BIXT:OTCMKTS) since the previous trading day is $0.00.
Bioxytran Inc (BIXT:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Bioxytran Inc (BIXT:OTCMKTS) since the previous trading day is 0.00%.
What is This Week's average sentiment score for Bioxytran Inc (BIXT:OTCMKTS)?
This Week's average sentiment score for Bioxytran Inc (BIXT:OTCMKTS) is 85 out of 100.
What is This Week's average sentiment for Bioxytran Inc (BIXT:OTCMKTS)?
This Week's sentiment for Bioxytran Inc (BIXT:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.